Allergic rhinitis in children with obesity: a modern view of the problem
https://doi.org/10.53529/2500-1175-2025-2-15-28
Abstract
Relevance. In recent decades, there has been an increase in a number of non-communicable chronic diseases and treated as a global health priority. There is an increase in the prevalence of allergic diseases, including allergic rhinitis (AR), and obesity in the pediatric population. In this regard, the study of AR in children with comorbid obesity is of particular interest.
The aim of the review is to summarize current data on the immunological and clinical-epidemiological features of AR in children with comorbid obesity.
Content. The review presents current information on the role of individual cytokines and adipokines in the development of chronic systemic inflammation in children with AR and obesity. An analysis of literature data on the significance of obesity as a possible risk factor for the development of AR in childhood is conducted. Clinical and epidemiological features are discussed, and individual studies are presented on some aspects of AR therapy in obese patients.
Conclusions. The analysis showed that the currently available data on the relationship between AR and overweight/obesity in children are contradictory and require further research.
About the Authors
A. E. Koroleva
Smolensk State Medical University
Russian Federation
Russian Federation
Anna E. Koroleva — Cand. Sci., Assistant Professor, Department of Children’s Diseases of the Medical and Dental Faculties
28 Krupskaya Str., Smolensk, 214019
V. V. Bekezin
Smolensk State Medical University
Russian Federation
Russian Federation
Vladimir V. Bekezin — Dr. Sci., Professor, Head, Department of Children’s Diseases of the Medical and Dental Faculties
28 Krupskaya Str., Smolensk, 214019
R. Y. Meshkova
Smolensk State Medical University
Russian Federation
Russian Federation
Raisa Y. Meshkova — Dr. Sci., Professor, Head, Department of Clinical Immunology and Allergology
28 Krupskaya Str., Smolensk, 214019
References
1. Passali D., Cingi C., Staffa P. et al. The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions. Asia Pacific Allergy. 2018; 8 (1): 1–15. https://doi.org/10.5415/apallergy.2018.8.e7.
2. Bousquet J., Anto J.M., Bachert C. et al. Allergic rhinitis. Nature reviews. Disease primers. 2020; 6 (1): 95. https://doi.org/10.1038/s41572-020-00227-0.
3. Zhou J., Luo F., Han Y. et al. Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies. Allergy: European Journal of Allergy and Clinical Immunology. 2020; 75 (5): 1272–1275. https://doi.org/10.1111/all.14143.
4. Kelishadi R., Roufarshbaf M., Soheili S. et al. Association of Childhood Obesity and the Immune System: A Systematic Review of Reviews. Childhood Obesity. 2017; 13 (4): 332–346. https://doi.org/10.1089/chi.2016.0176.
5. Migacheva N.B., Skvortsova O.V., Kaganova T.I., Ginzburg A.S. Paradoxes of the immune response in obesity. Effective Pharmacotherapy. 2023; 19 (28): 30–36. (In Russ.)
6. Recinella L., Orlando G., Ferrante C. et al. Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic and Cardiovascular Diseases. Frontiers in physiology. 2020; 11: 1–32. https://doi.org/10.3389/fphys.2020.578966.
7. Umano G.R., Pistone C., Tondina E. et al. Pediatric Obesity and the Immune System. Frontiers in Pediatrics. 2019; 7: 1–9. https://doi.org/10.3389/fped.2019.00487.
8. Yeo B.S.Y., Guan E.J., Ng K. et al. Association of Abnormal Body Weight and Allergic Rhinitis-A Systematic Review and Meta-Analysis. Clinical and Experimental Allergy. 2025; 55 (2): 142–165. https://doi.org/10.1111/cea.14604.
9. Tajima H., Pawankar R. Obesity and adiposity indicators in asthma and allergic rhinitis in children. Current opinion in allergy and clinical immunology. 2019; 19 (1): 7–11. https://doi.org/10.1097/ACI.0000000000000504.
10. Stefani C., Pecoraro L., Flodmark C.E. et al. Allergic Diseases and Childhood Obesity: A Detrimental Link? Biomedicines. 2023; 11: 2061. https://doi.org/10.3390/biomedicines11072061.
11. Wang X., Shen Y., Ke X. et al. Role of leptin/ILC2 axis in allergic rhinitis in obese children. International journal of pediatric otorhinolaryngology. 2022; 157. https://doi.org/10.1016/j.ijporl.2022.111127.
12. Wang X., Hu G., Shen Y. et al. Leptin mediated activation of group 2 innate lymphocytes aggravates the pathogenesis of allergic rhinitis in obese adults. 2022; 38 (12): 1118–1124.
13. Liu W., Zeng Q., Zhou L. et al. Association of leptin with disease severity and inflammation indicators in Chinese obese children with allergic rhinitis. Pediatric allergy and immunology. 2018; 29 (2): 186–193. https://doi.org/10.1111/pai.12856.
14. Hsueh K.C., Lin Y.J., Lin H.C. et al. Serum leptin and adiponectin levels correlate with severity of allergic rhinitis. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2010; 21 (1): 155–159. https://doi.org/10.1111/j.1399-3038.2009.00878.x.
15. Unal M., Eskandari G., Muşlu N. et al. Serum leptin levels in patients with allergic rhinitis. Otolaryngology-head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2006; 134 (2): 331–333. https://doi.org/10.1016/j.otohns.2005.11.021.
16. Zeng Q., Luo X., Han M. et al. Leptin/Osteopontin Axis Regulated Type 2T Helper Cell Response in Allergic Rhinitis with Obesity. Ebiomedicine. 2018; 32: 43–49. https://doi.org/10.1016/j.ebiom.2018.05.037.
17. Liu W., Zeng Q., Chen Y. et al. Role of leptin/osteopontin axis in the function of eosinophils in allergic rhinitis with obesity. Mediators of Inflammation. 2018: 1–10. https://doi.org/10.1155/2018/9138904.
18. Koroleva A.E., Bekezin V.V., Meshkova R.Ya., Demina E.G., Tsvetnaya I.N. Phenotypic markers of allergic rhinitis in children with overweight and obesity. Russian Bulletin of Perinatology and Pediatrics. 2023; 68 (4): 351. (In Russ.)
19. Kalpaklıoglu A.F., Baccioglu A., Yalim S.A. Does serum leptin levels differ between patients with rhinitis of allergic versus nonallergic etiology? The clinical respiratory journal. 2021; 15 (12): 1352–1358. https://doi.org/10.1111/crj.13440.
20. Shore S.A., Terry R.D., Flynt L. et al. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. The Journal of allergy and clinical immunology. 2006; 118 (2): 389–395. https://doi.org/10.1016/j.jaci.2006.04.021.
21. Wang H.R., Wei S.Z., Song X.Y. et al. IL-1β and Allergy: Focusing on Its Role in Allergic Rhinitis. Mediators of Inflammation. 2023: 1265449. https://doi.org/10.1155/2023/1265449.
22. 22. Han M.W., Kim S.H., Oh I. et al. Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2019; 18 (15): 58. https://doi.org/10.1186/s13223-019-0368-8.
23. Han M.W., Kim S.H., Oh I. et al. Obesity Can Contribute to Severe Persistent Allergic Rhinitis in Children through Leptin and Interleukin-1β. International Archives of Allergy and Immunology. 2021; 182 (6): 546–555. https://doi.org/10.1159/000512920.
24. Koroleva A.E., Bekezin V.V., Sergeeva I.N., Volkova E.A., Meshkova R.Ya. The role of IL-33 and IL-1β in the development of persistent allergic rhinitis in children with overweight/obesity. Russian Journal of Allergology. 2022; 19 (4): 472–482. (In Russ.) https://doi.org/10.36691/RJA1575.
25. Cayrol C., Girard J.P. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine. 2022; 156: 155891. https://doi.org/10.1016/j.cyto.2022.155891.
26. Hong H., Liao S., Chen F. et al. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020; 75 (11): 2794–2804. https://doi.org/10.1111/all.14526.
27. Chan B.C.L., Lam C.W.K., Tam L.S. et al. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives. Frontiers in immunology. 2019; 10: 364. https://doi.org/10.3389/fimmu.2019.00364.
28. Han J. M., Wu D., Denroche H.C. et al. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance. Journal of immunology. 2015. 10 (194): 4777–4783. https://doi.org/10.4049/jimmunol.1500020.
29. Lam E.P., Kariyawasam H.H., Rana B.M. IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa. The Journal of allergy and clinical immunology. 2016. 137 (5): 1514–1524. https://doi.org/10.1016/j.jaci.2015.10.019.
30. Matsushita K., Kato Y., Akasaki S. et al. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases. Allergology international: official journal of the Japanese Society of Allergology. 2015. 64 (3): 235–240. https://doi.org/10.1016/j.alit.2014.12.008.
31. Oliveira M.F., Talvani A., Rocha-Vieira E. IL-33 in obesity: where do we go from here? Inflammation research. 2019; 68 (3): 185–194. https://doi.org/10.1007/s00011-019-01214-2.
32. Glück J., Rymarczyk B., Rogala B. Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflammation research: official journal of the European Histamine Research Society. 2012; 61 (6): 547–550. doi: 10.1007/s00011-012-0443-9.
33. Lei Y., Yang H., Zhen L. Obesity is a risk factor for allergic rhinitis in children of Wuhan (China). Asia Pacific Аllergy. 2016; 6 (2): 101–104. https://doi.org/10.5415/apallergy.2016.6.2.101.
34. Saadeh D., Salameh P., Caillaud D. et al. High body mass index and allergies in schoolchildren: The french six cities study. BMJ Open Respiratory Research. 2014; 1 (1): e000054. https://doi.org/10.1136/bmjresp-2014-000054.
35. Baumann L.M., Romero K.M., Robinson C.L. et al. Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization. Clinical and Experimental Allergy. 2015; 45 (1): 192–199. https://doi.org/10.1111/cea.12379.
36. Lim M.S., Lee C.H., Sim S. et al. Physical Activity, Sedentary Habits, Sleep, and Obesity are Associated with Asthma, Allergic Rhinitis, and Atopic Dermatitis in Korean Adolescents. Yonsei Med J. 2017; 58 (5): 1040–1046. https://doi.org/10.3349/ymj.2017.58.5.1040.
37. Campbell E.A., Qian T., Miller J.M. et al. Identification of temporal condition patterns associated with pediatric obesity incidence using sequence mining and big data. International Journal of Obesity. 2020; 44 (8): 1753–1765. https://doi.org/10.1038/s41366-020-0614-7.
38. Vehapoglu A., Cakın Z.E., Kahraman F.U. et al. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case–control study. Journal of Pediatric Endocrinology and Metabolism. 2021; 34 (6): 727–732. https://doi.org/10.1515/jpem-2021-0051.
39. Kreißl S., Radon K., Dressel H. et al. Body mass index change and atopic diseases are not always associated in children and adolescents. Ann Allergy Asthma Immunol. 2014; 113 (4): 440–449. https://doi.org/10.1016/j.anai.2014.07.011.
40. Lin M.H., Hsieh C.J., Caffrey J.L. et al. Fetal Growth, Obesity, and Atopic Disorders in Adolescence: Retrospective Birth Cohort Study. Pediatric and Perinatal Epidemiology. 2015; 29 (5): 472–479. https://doi.org/10.1111/ppe.12215.
41. Mai X.M., Almqvist C., Nilsson L., Wickman M. Birth anthropometric measures, body mass index and allergic diseases in a birth cohort study (BAMSE). Archives of Disease in Childhood. 2007; 92 (10): 881–886. https://doi.org/.1136/adc.2006.110692.
42. Chang C.L., Ali G.B., Lodge C.J. et al. Associations between Body Mass Index Trajectories in the first two years of life and Allergic Rhinitis, Eczema and Food Allergy outcomes up to early adulthood. Pediatric Allergy and Immunology. 2022; 33 (3): e13765. https://doi.org/10.1111/pai.13765.
43. Weinmayr G., Forastiere F., Büchele G. et al. ISAAC Phase Two Study Group. Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two. PLoS One. 2014; 9 (12): e113996. https://doi.org/10.1371/journal.pone.0113996.
44. Kusunoki T., Morimoto T., Nishikomori R. et al. Obesity and the prevalence of allergic diseases in schoolchildren. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2008; 19 (6): 527–534. https://doi.org/10.1111/j.1399-3038.2007.00686.x.
45. Leung T.F., Kong A.P., Chan I.H. et al. Association between obesity and atopy in Chinese schoolchildren. International Archives of Allergy and Immunology. 2009; 149 (2): 1330–1340. https://doi.org/10.1159/000189196.
46. Skaaby T., Taylor A.E., Thuesen B.H. et al. Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization. Allergy. 2018; 73 (1): 153–164. https://doi.org/10.1111/all.13242.
47. Han Y.Y., Forno E., Gogna M. et al. Obesity and rhinitis in a nationwide study of children and adults in the United States. Journal of Allergy and Clinical Immunology. 2016; 137 (5): 1460–1465. https://doi.org/10.1016/j.jaci.2015.12.1307.
48. Girsh Y.V., Gerasimchik O.A. The role and place of bioimpedance analysis assessment of body composition of children and adolescents with different body mass. Bulletin of Siberian Medicine. 2018; 17 (2): 121–132. (In Russ.)
49. Javed A., Jumean M., Murad M.H. et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatric Obesity. 2015; 10 (3): 234–244. doi: 10.1111/ijpo.242.
50. Morąg B., Kozubek P., Gomułka K. Obesity and Selected Allergic and Immunological Diseases-Etiopathogenesis, Course and Management. Nutrients. 2023; 15 (17): 3813. https://doi.org/10.3390/nu15173813.
51. Nikolaev D.V., Rudnev S.G. Bioimpedance analysis: basics of the method, examination protocol and interpretation of results (lecture). Sports medicine: science and practice. 2012; 2: 29–37. (In Russ.)
52. Abdrakhmanova Sh.Z., Aringazina A.M., Adaeva A.A. Methods for school-age children nutritional status assessment: focus on anthropometric parameters. A review. 2023; 6 (25): 207–216. (In Russ.) https://doi.org/10.34689/SH.2023.25.6.024.
53. Li R.L., Wu C.T., Chen S.M. et al. Allergic rhinitis children with obesity are more vulnerable to air pollution: A cross sectional study. Scientific Report. 2023; 13: 3658. https://doi.org/10.1038/s41598-023-30388-3.
54. Bekezin V.V., Koroleva A.E., Sazonekova L.V., Volkova E.V., Meshkova R.Ya. Allergic rhinitis in children with overweight/ obesity: features of sensitization. Allergology and immunology in pediatrics. 2020; 63 (4): 29–35. (In Russ.) https://doi.org/10.24411/2500-1175-2020-1001.
55. Park D.Y., Kim Y.S., Kim J.H. et al. Association of body mass index and other factors with histamine skin reactivity in adults with allergic nasal symptoms. The American Journal of Rhinology & Allergy. 2015; 29 (6): 160–163. https://doi.org/10.2500/ajra.2015.29.4233.
56. Ramalho R., Almeida J., Beltrao M. et al. Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesity-asthma association? Experimental Lung Research. 2012; 38: 316–324. https://doi.org/10.3109/01902148.2012.699589.
57. Furukawa S., Asano K., Kobayashi H. Suppressive Activity of Adiponectin on the Development of Allergic Rhinitis in Mice. In Vivo. 2019; 33 (1): 93–98. https://doi.org/10.21873/invivo.11444.
58. Park J.H., Yoo E., Seo M.W. et al. Association between Physical Activity and Respiratory Diseases in Adolescents: An Age- and Gender-Matched Study. International journal of environmental research and public health. 2021; 18 (4): 1397. https://doi.org/10.1016/j.jshs.2020.09.009.
59. de Sá Pittondo M., Migueis D.P., Fujita R.R., et al. Effect of Body Weight on Response to Nasal Glucocorticoid Treatment in Allergic Rhinitis. Indian Journal of Otolaryngology and Head and Neck Surgery. 2024; 76 (1): 1002–1009. https://doi.org/10.1007/s12070-023-04344-6.
Review
For citations:
Koroleva A.E., Bekezin V.V., Meshkova R.Y. Allergic rhinitis in children with obesity: a modern view of the problem. Allergology and Immunology in Paediatrics. 2025;(2):15-28. (In Russ.) https://doi.org/10.53529/2500-1175-2025-2-15-28
Views:
38
Email this article 